India-based Dr. Reddy’s Laboratories has unveiled a new line of packaging solutions for its syrup bottles and blister packs in a bid to make them more convenient for patients.
Launched as part of its Purple Health initiative, the company has redesigned its blister packs and syrup bottles, which will be used for five of its brands.
The new packaging solutions are the result of a partnership with US-based design and consulting firm IDEO.
The five brands have been designed to help patients with several diseases, ranging from diarrhoea to oncology.
Planned to be initially used by the Indian market, the new solution will be launched in a phased manner for the company’s 25 brands over the next six months.
Developed using feedback from patients, doctors and pharmacists across India, the entire packaging initiative took a period of 24 months.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataDr. Reddy’s Laboratories India and emerging countries executive vice-president and head branded markets M. V. Ramana said, “Dr. Reddy’s is committed to addressing unmet patient needs through patient-centric innovation and we are very excited to introduce our new packaging for patients in India.
“We continue to make significant efforts to provide care beyond the pill and see Purple Health as our belief put into practice.”
The new patient-centric packaging aims to enhance therapy for more than 20 million patients annually.
The company stated that medicinal packaging has traditionally been designed to meet technical and regulatory requirements.
As a part of the new initiative, Dr. Reddy’s has also begun a structured system to evaluate its brand offerings on providing care beyond the pill.